Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1320232

Cover Image

PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1320232

Cancer Stem Cells Market with COVID-19 Impact Analysis, By Cancer Forms, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

PUBLISHED:
PAGES: 359 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 3250
PDF (5 User License)
USD 4650
PDF & Excel (Enterprise User License)
USD 5650

Add to Cart

REPORT HIGHLIGHT

Cancer Stem Cells Market size was valued at USD 1,056.7 Million in 2022, expanding at a CAGR of 9.1% from 2023 to 2030.

A subgroup of cells having stem cell-like characteristics that are present in tumors are known as cancer stem cells. They have the same capacity for self-renewal and cell cancer forms differentiation as regular stem cells. However, cancer stem cells are tumorigenic, meaning they can give rise to new cancer cells and aid in the spread of disease, in contrast to normal stem cells.

Cancer Stem Cells Market- Market Dynamics:

Growing prevalence of cancer diseases and rising investment in stem cell research is expected to propel the cancer stem cells demand.

The market for cancer stem cells has been significantly influenced by the rising incidence of cancer across the world. Research and treatments involving cancer stem cells are becoming more important as cancer continues to be the leading cause of death worldwide. The rate of new discoveries and the creation of innovative therapies has accelerated due to increased financing and investment in stem cell research, especially cancer stem cells. Nonprofit foundations, for-profit businesses, and government agencies have all contributed to this expansion. Understanding cancer stem cells and their function in tumor initiation and progression has improved because of developments in the fields of genomics, molecular biology, and immunotherapy.

Pharmaceutical corporations are funding clinical trials and research into cancer stem cells to create novel treatments that specifically target these cells. Positive trial outcomes can spur market expansion. Clinical studies are crucial for confirming the security and effectiveness of prospective medicines.

Cancer Stem Cells Market- Key Insights:

  • As per the analysis shared by our research analyst, the global Cancer Stem Cells market is estimated to grow annually at a CAGR of around 9.1% over the forecast period (2023-2030)
  • The Cancer Stem Cells industry is projected to grow at a significant rate due to the growing focus on animal health and nutrition.
  • Based on Application, targeted cancerous stem cells segment was predicted to show maximum market share in the year 2022.
  • Based on Cancer Forms, segmentation, breast cancer segment was the leading in 2022
  • On the basis of region, North America was the leading revenue generator in 2022.

Cancer Stem Cells Market- Segmentation Analysis:

The Global Cancer Stem Cells Market is segmented on the basis of Cancer Forms, Application, System, and Region.

The market is divided into seven categories based on Cancer Forms: breast, blood, brain, lung, pancreatic, bladder, and others. The rocket launchers segment dominates the market. Increasing demand rocket launching system is contributing to market growth.

The market is divided into two categories based on Application: targeted cancerous stem cells, and stem-cell based cancer therapy. The targeted cancerous stem cells segment dominates the market. Growing prevalence of small stem cells is expected to boost the market growth.

Cancer Stem Cells Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Cancer Stem Cells Market- Competitive Landscape:

Owing to the increasing advancement in healthcare and genetic engineering, which influence the Cancer Stem Cells market. Healthcare facilities including application providers compete on various factors, such as cancer therapy, reputation, and availability. Some of the primary techniques, and strategies used by corporations to consolidate their reach and expand their market share include new product launches, R&D expenditure, developing its distribution network and mergers & acquisitions. Some of the recent developments are mentioned below.

Recent Developments:

In June 2022, BlueRock Therapeutics has introduced new cell treatment site in Germany to enhance its clinical capabilities in Europe.

Key features of the study:

  • This proposed research study on Cancer Stem Cells market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Cancer Stem Cells market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Cancer Stem Cells market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Cancer Stem Cells market
  • Impact of COVID-19 on Cancer Stem Cells market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Cancer Stem Cells market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Cancer Stem Cells market, we have also included competitive landscape and key innovator analysis for the Cancer Stem Cells market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial inspection and strategic initiatives of players operating in the Cancer Stem Cells market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Cancer Stem Cells market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CANCER STEM CELLS MARKET KEY PLAYERS

  • Thermo Fisher Scientific, Inc.
  • AbbVie, Inc.
  • Merck KGaA
  • Bionomics
  • Lonza
  • Stemline Therapeutics, Inc.
  • Miltenyi Biotec
  • PromoCell GmbH
  • MacroGenics, Inc
  • OncoMed Pharmaceuticals, Inc.
  • Irvine Scientific
  • STEMCELL Technologies Inc.
  • BlueRock Therapeutics
  • Sino Biological Inc.
  • Biotime Inc.

GLOBAL CANCER STEM CELLS MARKET, BY CANCER FORMS

  • Breast
  • Blood
  • Brain
  • Lung
  • Pancreatic
  • Bladder
  • Others

GLOBAL CANCER STEM CELLS MARKET, BY APPLICATION

  • Targeted Cancerous Stem Cells
  • Stem-cell based Cancer Therapy

GLOBAL CANCER STEM CELLS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA
Product Code: ANV1543

Table of Contents

1. Cancer Stem Cells Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cancer Stem Cells Market Snippet by Cancer Forms
    • 2.1.2. Cancer Stem Cells Market Snippet by Application
    • 2.1.3. Cancer Stem Cells Market Snippet by Country
    • 2.1.4. Cancer Stem Cells Market Snippet by Region
  • 2.2. Competitive Insights

3. Cancer Stem Cells Key Market Trends

  • 3.1. Cancer Stem Cells Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cancer Stem Cells Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cancer Stem Cells Market Opportunities
  • 3.4. Cancer Stem Cells Market Future Trends

4. Cancer Stem Cells Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cancer Stem Cells Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Cancer Stem Cells Market Landscape

  • 6.1. Cancer Stem Cells Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cancer Stem Cells Market - By Cancer Forms

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Cancer Forms, 2022 & 2030 (%)
    • 7.1.2. Breast
    • 7.1.3. Blood
    • 7.1.4. Brain
    • 7.1.5. Lung
    • 7.1.6. Pancreatic
    • 7.1.7. Bladder
    • 7.1.8. Others

8. Cancer Stem Cells Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Product, 2022 & 2030 (%)
    • 8.1.2. Targeted Cancerous Stem Cells
    • 8.1.3. Stem-cell based Cancer Therapy

9. Cancer Stem Cells Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Cancer Stem Cells Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.2.6.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.2.7.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Cancer Stem Cells Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.10.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.11.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.12.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.13.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.14.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Cancer Stem Cells Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.7. India
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. India Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.4.7.4. India Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.7.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.8. China
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. China Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.4.8.4. China Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.8.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.9. Japan
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. Japan Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.4.9.4. Japan Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.9.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.10. South Korea
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. South Korea Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.4.10.4. South Korea Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.10.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.11. Australia
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Australia Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Australia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.11.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.12. Thailand
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Thailand Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Thailand Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.12.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.13. Indonesia
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Indonesia Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Indonesia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.13.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.14. Philippines
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Philippines Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Philippines Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.14.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.15. Rest of APAC
      • 9.4.15.1. Overview
      • 9.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.15.3. Rest of APAC Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.4.15.4. Rest of APAC Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Cancer Stem Cells Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.7. Brazil
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Brazil Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Brazil Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.7.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.8. Mexico
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Mexico Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Mexico Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.8.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.9. Argentina
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Argentina Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Argentina Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.9.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.10. Colombia
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Colombia Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Colombia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.10.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.11. Rest of LATAM
      • 9.5.11.1. Overview
      • 9.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.11.3. Rest of LATAM Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.5.11.4. Rest of LATAM Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Cancer Stem Cells Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.7. Saudi Arabia
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. Saudi Arabia Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.6.7.4. Saudi Arabia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.8. United Arab Emirates
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. United Arab Emirates Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.6.8.4. United Arab Emirates Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.9. Israel
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Israel Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Israel Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.9.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.10. Turkey
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Turkey Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Turkey Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.10.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.11. Algeria
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Algeria Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Algeria Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.11.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.12. Egypt
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Egypt Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Egypt Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.12.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.13. Rest of MEA
      • 9.6.13.1. Overview
      • 9.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.13.3. Rest of MEA Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.6.13.4. Rest of MEA Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Cancer Stem Cells Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Thermo Fisher Scientific, Inc.
    • 10.2.2. AbbVie, Inc.
    • 10.2.3. Merck KGaA
    • 10.2.4. Bionomics
    • 10.2.5. Lonza
    • 10.2.6. Stemline Therapeutics, Inc.
    • 10.2.7. Miltenyi Biotec
    • 10.2.8. PromoCell GmbH
    • 10.2.9. MacroGenics, Inc
    • 10.2.10. OncoMed Pharmaceuticals, Inc.
    • 10.2.11. Irvine Scientific
    • 10.2.12. STEMCELL Technologies Inc.
    • 10.2.13. BlueRock Therapeutics
    • 10.2.14. Sino Biological Inc.
    • 10.2.15. Biotime Inc.

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us
Product Code: ANV1543

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Cancer Stem Cells Market: Cancer Forms Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Cancer Forms
  • TABLE Global Cancer Stem Cells Market, by Cancer Forms 2018-2030 (USD Million)
  • TABLE Cancer Stem Cells Market: Product Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global Cancer Stem Cells Market, by Product 2018-2030 (USD Million)
  • TABLE Cancer Stem Cells Market: Regional snapshot (2022)
  • TABLE Cancer Stem Cells Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Cancer Stem Cells Market, by Application 2018-2030 (USD Million)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Cancer Stem Cells Market, by Region 2018-2030 (USD Million)
  • TABLE North America Cancer Stem Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Cancer Stem Cells Market, by Cancer Forms, 2018-2030 (USD Million)
  • TABLE North America Cancer Stem Cells Market, by Product, 2018-2030 (USD Million)
  • TABLE North America Cancer Stem Cells Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Cancer Stem Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Cancer Stem Cells Market, by Cancer Forms, 2018-2030 (USD Million)
  • TABLE Europe Cancer Stem Cells Market, by Product, 2018-2030 (USD Million)
  • TABLE Europe Cancer Stem Cells Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cancer Stem Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cancer Stem Cells Market, by Cancer Forms, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cancer Stem Cells Market, by Product, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cancer Stem Cells Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Cancer Stem Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Cancer Stem Cells Market, by Cancer Forms, 2018-2030 (USD Million)
  • TABLE Latin America Cancer Stem Cells Market, by Product, 2018-2030 (USD Million)
  • TABLE Latin America Cancer Stem Cells Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cancer Stem Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cancer Stem Cells Market, by Cancer Forms, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cancer Stem Cells Market, by Product, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cancer Stem Cells Market, by Application, 2018-2030 (USD Million)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!